A0001 (ARTO trial-NCT03449719): Long-term overall survival analysis from a randomized phase II trial testing the benefit of stereotactic body radiotherapy addition to abiraterone acetate in oligometastatic castrate resistant prostate cancer patients
作者
G. Francolini,Niccolò Bertini,Saverio Caini,V. Di Cataldo,Pietro Garlatti,M. Aquilano,Alessio Bruni,G. Ingrosso,Rolando Maria D’Angelillo,Luca Tagliaferri,Matteo Augugliaro,Luca Triggiani,S. Parisi,L. Masieri,Riccardo Campi,G. Simontacchi,R.K. Valincenti,Chad Z. Tang,L. Livi